{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:20:03Z","timestamp":1788985203486,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtct.2026.08.002","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:46:14Z","timestamp":1786059974000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Our Approach to Treating Concurrent Acute Gastrointestinal Graft Versus Host Disease and Transplant Associated Thrombotic Microangiopathy"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8627-6408","authenticated-orcid":false,"given":"Pooja","family":"Khandelwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1791-7718","authenticated-orcid":false,"given":"Sonata","family":"Jodele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.08.002_bib0001","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood.V95.9.2754.009k25_2754_2759","article-title":"The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation","volume":"95","author":"Hill","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.08.002_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1033490","article-title":"Role of endothelial cells in graft-versus-host disease","volume":"13","author":"Neidemire-Colley","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.002_bib0003","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/cancers15030680","article-title":"Endothelial dysfunction syndromes after allogeneic stem cell transplantation","volume":"15","author":"Vythoulkas","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtct.2026.08.002_bib0004","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/17474086.2021.1968823","article-title":"Endothelial dysfunction and vascular complications after allogeneic hematopoietic cell transplantation: an expert analysis","volume":"14","author":"Eftychidis","year":"2021","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jtct.2026.08.002_bib0005","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbmt.2019.08.025","article-title":"Distribution of transplantation-associated thrombotic microangiopathy (TA-TMA) and comparison between renal TA-TMA and intestinal TA-TMA: autopsy study","volume":"26","author":"Yamada","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.08.002_bib0006","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/15258160050079407","article-title":"Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors","volume":"9","author":"Ferrara","year":"2000","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1016\/j.jtct.2026.08.002_bib0007","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.beha.2008.02.003","article-title":"Vascular endothelium and graft-versus-host disease","volume":"21","author":"Biedermann","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jtct.2026.08.002_bib0008","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41409-021-01283-0","article-title":"Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis","volume":"56","author":"Young","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.08.002_bib0009","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.immuni.2007.03.011","article-title":"Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44","volume":"26","author":"Hidalgo","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jtct.2026.08.002_bib0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/ejh.12996","article-title":"Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome","volume":"100","author":"Zhang","year":"2018","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2026.08.002_bib0011","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.bbmt.2015.06.016","article-title":"Histologic features of intestinal thrombotic microangiopathy in pediatric and young adult patients after hematopoietic stem cell transplantation","volume":"21","author":"El-Bietar","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.08.002_bib0012","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.5858\/arpa.2016-0599-RA","article-title":"A complete histologic approach to gastrointestinal biopsy from hematopoietic stem cell transplant patients with evidence of transplant-associated gastrointestinal thrombotic microangiopathy","volume":"141","author":"Warren","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtct.2026.08.002_bib0013","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.2169\/internalmedicine.42.1228","article-title":"Ischemic colitis as a manifestation of thrombotic microangiopathy following bone marrow transplantation","volume":"42","author":"Komeno","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.jtct.2026.08.002_bib0014","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1620\/tjem.227.31","article-title":"Diagnosis of intestinal graft-versus-host disease and thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"227","author":"Yamada-Fujiwara","year":"2012","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.jtct.2026.08.002_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/bmt.2008.419","article-title":"Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy","volume":"44","author":"Inamoto","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.08.002_bib0016","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.bmt.1704512","article-title":"Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease","volume":"33","author":"Nishida","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.08.002_bib0017","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1182\/bloodadvances.2019000791","article-title":"The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease","volume":"3","author":"Srinagesh","year":"2019","journal-title":"Blood Adv"},{"issue":"14","key":"10.1016\/j.jtct.2026.08.002_bib0018","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1182\/bloodadvances.2026019747","article-title":"TA-TMA and GVHD are distinct consequences of endothelial injury: a MIDAS consortium study","volume":"10","author":"Hahn","year":"2026","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.08.002_bib0019","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s12185-026-04162-w","article-title":"Clinical correlation between plasma biomarker levels and post-transplant complications of allogeneic hematopoietic stem cell transplantation in children","volume":"123","author":"Yang","year":"2026","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2026.08.002_bib0020","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMc1700185","article-title":"ST2 and endothelial injury as a link between GVHD and microangiopathy","volume":"376","author":"Rotz","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2026.08.002_bib0021","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.rcl.2015.06.009","article-title":"Radiological evaluation of bowel ischemia","volume":"53","author":"Dhatt","year":"2015","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.jtct.2026.08.002_bib0022","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jtct.2022.11.015","volume":"29","author":"Schoettler","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.08.002_bib0023","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/s41409-023-02089-y","article-title":"Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation","volume":"58","author":"Alhomoud","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.08.002_bib0024","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/bloodadvances.2018020321","article-title":"Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD","volume":"2","author":"Wall","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.08.002_bib0025","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1182\/bloodadvances.2020002007","article-title":"Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT","volume":"4","author":"Matsui","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.08.002_bib0026","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.12669\/pjms.316.8357","article-title":"Use of recombinant factor VIIa in uncontrolled gastrointestinal bleeding after hematopoietic stem cell transplantation among patients with thrombocytopenia","volume":"31","author":"Tang","year":"2015","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.jtct.2026.08.002_bib0027","first-page":"373","article-title":"Control of severe bleeding from acute GvHD by treatment with tranexamic acid","volume":"43","author":"Hasenkamp AB","year":"2009","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jtct.2026.08.002_bib0028","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1182\/bloodadvances.2021006523","article-title":"Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT","volume":"6","author":"Mizuno","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.08.002_bib0029","first-page":"1049","article-title":"Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab","volume":"135","author":"Jodele","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.08.002_bib0030","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood.2023022526","article-title":"A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation-associated TMA","volume":"143","author":"Jodele","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.08.002_bib0031","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jtct.2024.03.019","volume":"30","author":"Benitez Carabante","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.08.002_bib0032","article-title":"Efficacy and safety of eculizumab in the treatment of transplant-associated thrombotic microangiopathy: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.jtct.2026.08.002_bib0033","doi-asserted-by":"crossref","first-page":"887.e1","DOI":"10.1016\/j.jtct.2026.04.026","article-title":"Eculizumab for pediatric hematopoietic cell transplant-associated thrombotic microangiopathy: real-world response rates, predictors of poor response, and an optimal time point for treatment response assessment","volume":"32","author":"Schoettler","year":"2026","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.08.002_bib0034","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41409-022-01852-x","article-title":"Use of eculizumab in children with allogeneic haematopoietic stem cell transplantation associated thrombotic microangiopathy - a multicentre retrospective PDWP and IEWP EBMT study","volume":"58","author":"Svec","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.08.002_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27388","article-title":"Multiple bloodstream infections in pediatric stem cell transplant recipients: a case series","volume":"65","author":"Grossmann","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2026.08.002_bib0036","doi-asserted-by":"crossref","first-page":"503.e501","DOI":"10.1016\/j.jtct.2025.11.037","article-title":"Outcomes of terminal complement blockade in adults with high-risk transplant-associated thrombotic microangiopathy: a comparative analysis","volume":"32","author":"Alhomoud","year":"2026","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.08.002_bib0037","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/ajh.70022","article-title":"Eculizumab is associated with increased infection rates and infection related mortality in children with thrombotic microangiopathy after HCT","volume":"100","author":"Schoettler","year":"2025","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2026.08.002_bib0038","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.bbmt.2016.03.032","article-title":"Terminal complement blockade after hematopoietic stem cell transplantation is safe without meningococcal vaccination","volume":"22","author":"Jodele","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.08.002_bib0039","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.bbmt.2016.06.002","article-title":"Healthcare burden, risk factors, and outcomes of mucosal barrier injury laboratory-confirmed bloodstream infections after stem cell transplantation","volume":"22","author":"Dandoy","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.08.002_bib0040","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1182\/bloodadvances.2023011078","article-title":"Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy","volume":"8","author":"Schoettler","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.08.002_bib0041","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1182\/bloodadvances.2024012561","article-title":"The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD","volume":"8","author":"DeFilipp","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.08.002_bib0042","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease","volume":"382","author":"Zeiser","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2026.08.002_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.02.002","article-title":"Ruxolitinib inhibits ifngamma licensing of human bone marrow derived mesenchymal stromal cells","volume":"27","author":"Ryan","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.08.002_bib0044","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/bloodadvances.2020001515","article-title":"Interferon-complement loop in transplant-associated thrombotic microangiopathy","volume":"4","author":"Jodele","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.08.002_bib0045","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10875-020-00789-4","article-title":"Thinking beyond HLH: clinical features of patients with concurrent presentation of hemophagocytic lymphohistiocytosis and thrombotic microangiopathy","volume":"40","author":"Gloude","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jtct.2026.08.002_bib0046","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.transproceed.2021.07.043","article-title":"Predictors of transplant-associated thrombotic microangiopathy in patients with overlap or chronic graft-vs-host-disease","volume":"53","author":"Gavriilaki","year":"2021","journal-title":"Transplant Proc"},{"issue":"12","key":"10.1016\/j.jtct.2026.08.002_bib0047","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1182\/bloodadvances.2026019704","article-title":"Endothelial activation and damage associated with steroid-refractory aGVHD is counteracted by ruxolitinib","volume":"10","author":"De Moner","year":"2026","journal-title":"Blood Adv"},{"issue":"92","key":"10.1016\/j.jtct.2026.08.002_bib0048","first-page":"30","article-title":"Integrins and L-selectin in lymphocyte-endothelium interactions and homing into gut-associated tissue","author":"Hamann","year":"1993","journal-title":"Behring Inst Mitt"},{"key":"10.1016\/j.jtct.2026.08.002_bib0049","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1182\/blood-2003-03-0957","article-title":"LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease","volume":"103","author":"Petrovic","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.08.002_bib0050","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1038\/s41591-024-03016-4","article-title":"Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial","volume":"30","author":"Chen","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jtct.2026.08.002_bib0051","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28968","article-title":"alpha4beta7 Integrin expression and blockade in pediatric and young adult gastrointestinal graft-versus-host disease","volume":"68","author":"Ibrahimova","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2026.08.002_bib0052","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/s41409-018-0364-5","article-title":"Anti-alpha4beta7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease","volume":"54","author":"Danylesko","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.08.002_bib0053","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1182\/blood-2017-11-815746","article-title":"alpha(1)-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease","volume":"131","author":"Magenau","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.08.002_bib0054","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.bbmt.2020.05.014","article-title":"Human-derived alpha1-antitrypsin is still efficacious in heavily pretreated patients with steroid-resistant gastrointestinal graft-versus-host disease","volume":"26","author":"Giannoni","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.08.002_bib0055","doi-asserted-by":"crossref","DOI":"10.1101\/2022.03.18.484920","article-title":"Alpha-1 antitrypsin limits neutrophil extracellular trap disruption of airway epithelial barrier function","volume":"13","author":"Hudock","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2026.08.002_bib0056","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/ATVBAHA.118.311150","article-title":"Neutrophil extracellular traps induce endothelial cell activation and tissue factor production through interleukin-1alpha and cathepsin G","volume":"38","author":"Folco","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtct.2026.08.002_bib0057","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood-2017-05-782870","article-title":"Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD","volume":"130","author":"Gloude","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.08.002_bib0058","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1200\/JCO.20.01086","article-title":"Phase II trial of costimulation blockade with abatacept for prevention of acute GVHD","volume":"39","author":"Watkins","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2026.08.002_bib0059","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd1989","article-title":"Abatacept","volume":"5","author":"Moreland","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jtct.2026.08.002_bib0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.trim.2016.08.009","article-title":"T cell costimulation blockade for hyperacute steroid refractory graft versus-host disease in children undergoing haploidentical transplantation","volume":"39","author":"Jaiswal","year":"2016","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.jtct.2026.08.002_bib0061","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1182\/blood.2023023444","article-title":"Evidence for antigen presentation by human neutrophils","volume":"143","author":"Moffat","year":"2024","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jtct.2026.08.002_bib0062","first-page":"3074","article-title":"Neutrophil extracellular traps, endothelial injury and use of abatacept for graft versus host disease prophylaxis","volume":"111","author":"Ibrahimova","year":"2026","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2026.08.002_bib0063","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1182\/bloodadvances.2025017197","article-title":"Abatacept improves posttransplant survival and reduces endothelial injury syndromes in beta-thalassemia major","volume":"9","author":"Khandelwal","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.08.002_bib0064","doi-asserted-by":"crossref","first-page":"454.e451","DOI":"10.1016\/j.jtct.2024.01.080","article-title":"Use of teduglutide in the management of gastrointestinal graft-versus-host disease in children and young adults","volume":"30","author":"Ramos","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.08.002_bib0065","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41409-025-02586-2","article-title":"Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey","volume":"60","author":"Brehm","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.08.002_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1495640","article-title":"Clinical impacts of total parenteral nutrition in hematopoietic stem cell transplantation patients with high nutritional risk","volume":"11","author":"Yang","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.jtct.2026.08.002_bib0067","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jtct.2025.12.891","article-title":"From standard formulas to individualize care: optimizing HSCT nutrition through metabolic cart assessments","volume":"32","author":"Taggart","year":"2026","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.08.002_bib0068","first-page":"210","article-title":"Exocrine pancreatic insufficiency and graft-versus-host disease","volume":"115","author":"Lopez Cardona","year":"2023","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.jtct.2026.08.002_bib0069","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1192084","article-title":"From support to therapy: rethinking the role of nutrition in acute graft-versus-host disease","volume":"14","author":"Limpert","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2026.08.002_bib0070","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.bbmt.2018.05.019","article-title":"Single ultra-high-dose cholecalciferol to prevent vitamin D deficiency in pediatric hematopoietic stem cell transplantation","volume":"24","author":"Wallace","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.08.002_bib0071","doi-asserted-by":"crossref","first-page":"1001.e1001","DOI":"10.1016\/j.jtct.2021.08.030","article-title":"Ultra-high dose vitamin D in pediatric hematopoietic stem cell transplantation: a nonrandomized controlled trial","volume":"27","author":"Bhandari","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.08.002_bib0072","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood.2023022865","article-title":"A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults","volume":"143","author":"Khandelwal","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.08.002_bib0073","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/bfm.2018.0199","article-title":"A pilot study of human milk to reduce intestinal inflammation after bone marrow transplant","volume":"14","author":"Khandelwal","year":"2019","journal-title":"Breastfeed Med"},{"key":"10.1016\/j.jtct.2026.08.002_bib0074","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jtct.2025.12.858","article-title":"2\u2019-fucosyllactose (human milk oligosaccharide)reduces dysbiosis and acute GI GVHD in children and young adults following HSCT: a prospective,single center phase II study","volume":"32","author":"Ramos","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.08.002_bib0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11899-018-0435-0","article-title":"Rethinking antimicrobial prophylaxis in the transplant patient in the world of emerging resistant organisms-where are we today?","volume":"13","author":"Horton","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.jtct.2026.08.002_bib0076","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.transci.2016.04.007","article-title":"New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"54","author":"Jodele","year":"2016","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtct.2026.08.002_bib0077","article-title":"Narsoplimab: first approval","author":"Shirley","year":"2026","journal-title":"Drugs"},{"key":"10.1016\/j.jtct.2026.08.002_bib0078","article-title":"Translating biomarker insights into practice: a path forward in TA-TMA management","volume":"12","author":"Jodele","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jtct.2026.08.002_bib0079","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00277-026-06756-0","article-title":"Use of narsoplimab for eculizumab-refractory adult transplant-associated thrombotic microangiopathy (TA-TMA)","volume":"105","author":"Young","year":"2026","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2026.08.002_bib0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/bloodadvances.2025017540","article-title":"Survival in adults with high-risk TA-TMA: a comparative analysis of narsoplimab vs supportive care","volume":"10","author":"Matsui","year":"2026","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.08.002_bib0081","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/ajh.70044","article-title":"Narsoplimab results in excellent survival in adults and children with hematopoietic cell transplant associated thrombotic microangiopathy (TA-TMA)","volume":"100","author":"Schoettler","year":"2025","journal-title":"Am J Hematol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600607X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600607X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:01:28Z","timestamp":1788984088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663672600607X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":81,"alternative-id":["S266663672600607X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.002","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Our Approach to Treating Concurrent Acute Gastrointestinal Graft Versus Host Disease and Transplant Associated Thrombotic Microangiopathy","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}